Press release
Tuberculosis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Serum Institute of India, AnHui Longcom Biologic, Biofabri, Immunitor, GlaxoSmithKline, Quratis, LegoChem, Aeras
"Tuberculosis Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Tuberculosis Therapeutics Market.
The report provides a detailed description of the Tuberculosis drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Tuberculosis Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/tuberculosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Tuberculosis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Tuberculosis therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Tuberculosis treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Tuberculosis drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Tuberculosis treatment market.
Learn More about the Clinical and Commercial Development Activities in the Tuberculosis Therapeutics Domain @
https://www.delveinsight.com/report-store/tuberculosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Tuberculosis Therapeutics Analysis
There are approx. 35+ key companies developing therapies for Tuberculosis. Currently, Qurient Co is leading the therapeutics market with its Tuberculosis drug candidates in the mid to advanced stage of clinical development.
Tuberculosis Companies in the Therapeutics Market Include:
• Serum Institute of India Pvt. Ltd.
• AnHui Longcom Biologic Pharmacy
• Biofabri, S.L
• Immunitor LLC
• Shanghai Jiatan Pharmatech
• GlaxoSmithKline
• Archivel Farma S.L.
• LegoChem Biosciences
• Quratis Inc
• Aeras
• Qurient Co.
• Sequella, Inc.
• Otsuka Pharmaceutical
• Vaxil Biotherapeutics
• Faron Pharmaceuticals
• Tianjin CanSino Biotechnology
• Global Alliance for TB Drug Development
• Spero Therapeutics
And Many Others
Emerging and Marketed Tuberculosis Therapies Covered in the Report Include:
• Telacebec (Q203): Qurient Co
• VPM1002: Serum Institute of India
And Many More
Get an in-depth Assessment of the Emerging Therapies and Tuberculosis Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/tuberculosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Tuberculosis Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Tuberculosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Tuberculosis Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/tuberculosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Tuberculosis Current Treatment Patterns
4. Tuberculosis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Tuberculosis Late-Stage Products (Phase-III)
7. Tuberculosis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Tuberculosis Discontinued Products
13. Tuberculosis Product Profiles
14. Tuberculosis Companies
15. Tuberculosis Drugs
16. Dormant and Discontinued Products
17. Tuberculosis Unmet Needs
18. Tuberculosis Future Perspectives
19. Tuberculosis Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/tuberculosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Pulmonology Devices Market
https://www.delveinsight.com/report-store/pulmonology-devices-market
Small Cell Lung Cancer Market
https://www.delveinsight.com/report-store/small-cell-lung-cancer-market
Bronchiectasis Market
https://www.delveinsight.com/report-store/bronchiectasis-market
Lennox Gastaut Syndrome Market
https://www.delveinsight.com/report-store/lennox-gastaut-syndrome-market
Holter Monitor Market
https://www.delveinsight.com/report-store/holter-monitor-market
Muscle Invasive Bladder cancer Market
https://www.delveinsight.com/report-store/muscle-invasive-bladder-cancer-market
Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market
Anesthesia Machines Market
https://www.delveinsight.com/report-store/anesthesia-workstation-machines-market
Secondary Myelofibrosis Market
https://www.delveinsight.com/report-store/secondary-myelofibrosis-market
Guillain-Barre Syndrome (GBS) Market
https://www.delveinsight.com/report-store/guillain-barre-syndrome-gbs-market
Hepatitis A Market
https://www.delveinsight.com/report-store/hepatitis-a-market
Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-market
Mucinous Cystic Neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market
Overt Hepatic Encephalopathy Market
https://www.delveinsight.com/report-store/overt-hepatic-encephalopathy-market
Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/familial-hypercholesterolemia-market-report
Lateral Epicondylitis (Tennis Elbow) Disease Market
https://www.delveinsight.com/report-store/lateral-epicondylitis-tennis-elbow-disease-market
Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market
Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market
Neurovascular Thrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market
Neurothrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market
Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market
Venous Leg Ulcer Market
https://www.delveinsight.com/report-store/venous-leg-ulcer-market
Genital Herpes Market
https://www.delveinsight.com/report-store/genital-herpes-market-forecast
Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market
Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market
Lymphoedema Market
https://www.delveinsight.com/report-store/lymphoedema-market
Neurotrophic Keratopathy Market
https://www.delveinsight.com/report-store/neurotrophic-keratopathy-market
Oncolytic Virus Cancer Therapy Market
https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market
Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market
Advanced Wound Care (AWC) Market
https://www.delveinsight.com/report-store/advanced-wound-care-market
Opioid-related Disorders Market
https://www.delveinsight.com/report-store/opioid-related-disorders-market
Ankylosing Spondylitis (AS) Market
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market
Chronic Insomnia Market
https://www.delveinsight.com/report-store/chronic-insomnia-market
Microscopic Polyangiitis (MPA) Market
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market
Esophageal Squamous Carcinoma Market
https://www.delveinsight.com/report-store/esophageal-squamous-carcinoma-market
Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market
Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Idiopathic Interstitial Pneumonia Market
https://www.delveinsight.com/report-store/idiopathic-interstitial-pneumonia-market
Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market
Dyslipidemia Market
https://www.delveinsight.com/report-store/dyslipidemia-market
Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market
Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market
Alpha-Antitrypsin Deficiency Market
https://www.delveinsight.com/report-store/alpha-antitrypsin-deficiency-market
Factor XA Inhibitor Market
https://www.delveinsight.com/report-store/factor-xa-inhibitor-market
Undifferentiated Pleomorphic Sarcoma Market
https://www.delveinsight.com/report-store/undifferentiated-pleomorphic-sarcoma-market
Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market
Primary Progressive Multiple Sclerosis (PPMS) Market
https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market
Thalassemia Market
https://www.delveinsight.com/report-store/thalassemia-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tuberculosis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Serum Institute of India, AnHui Longcom Biologic, Biofabri, Immunitor, GlaxoSmithKline, Quratis, LegoChem, Aeras here
News-ID: 3287422 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does.
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…
